Fedorocko P, Macková N O
Department of Cellular and Molecular Biology, Faculty of Sciences, P. J.Safárik University, Kosice, Slovakia.
Int J Immunopharmacol. 2000 Nov;22(11):989-99. doi: 10.1016/s0192-0561(00)00063-1.
Data in this report describes the effect of a single injection of bacterial lysate IRS-19 prior to irradiation of C57Bl/6 mice on recovery of colony-forming cells (CFC) after sublethal and lethal doses of radiation. The injection of IRS-19 promoted an earlier recovery of colony-forming cells in the bone marrow and spleen. For example, 5 and 9 days after 7.5 Gy irradiation, the number of CFU-S per femur was approximately 1.7-2.3-fold higher in IRS-19-injected mice than in saline-injected mice. Also, pretreatment of mice with IRS-19 induced an increase in the number of endogenous haemopoietic stem cells (endoCFU-S). In the postradiation period (5-21 days) significantly increased bone marrow and spleen cellularity and accelerated myelopoietic regeneration (committed progenitor granulocyte-macrophage-colony-forming cells, GM-CFC) in the bone marrow and spleen compared with saline-treated controls. At the time of presumed irradiation, (i.e. 24 h after administration of the drug to the non-irradiated mice), there was no significant difference between the control mice and mice treated with IRS-19 in numbers of femoral and spleen GM-CFC. In contrast, the number of nucleated femoral cells decreased significantly in the group treated with IRS-19. Moreover, treatment with IRS-19 caused a sustained increase in serum colony-stimulating activity which was followed by an enhanced repopulation of GM-CFC in the femoral marrow and spleen. Administration of the agent 24 h prior to irradiation rather than postirradiation appeared most effective with respect to radioprotection. Intravenous rather than i.p. and p.o. was the most effective route of administration in the mouse. Furthermore, single, high-dose injection appeared to be more effective than repeated, lower dose injections. Results suggest that the radioprotective properties associated with the administration of IRS-19 are largely a consequence of the induction of haemopoietic colony-stimulating activities and potentially the activation and/or enhancement of cytokine cascades in the recipient animals. These changes may ultimately impact the cell cycle profile of the haemopoietic cells and therefore their ability to withstand and/or recover from radiation insult.
本报告中的数据描述了在对C57Bl/6小鼠进行辐照之前单次注射细菌裂解物IRS-19对亚致死剂量和致死剂量辐射后集落形成细胞(CFC)恢复的影响。注射IRS-19促进了骨髓和脾脏中集落形成细胞的更早恢复。例如,在7.5 Gy辐照后5天和9天,注射IRS-19的小鼠每根股骨的脾集落形成单位(CFU-S)数量比注射生理盐水的小鼠高出约1.7至2.3倍。此外,用IRS-19对小鼠进行预处理可诱导内源性造血干细胞(endoCFU-S)数量增加。在辐射后时期(5至21天),与生理盐水处理的对照组相比,骨髓和脾脏细胞数量显著增加,骨髓和脾脏中的骨髓生成再生(定向祖细胞粒细胞-巨噬细胞集落形成细胞,GM-CFC)加速。在假定的辐照时间(即对未辐照小鼠给药后24小时),对照组小鼠和用IRS-19处理的小鼠在股骨和脾脏GM-CFC数量上没有显著差异。相比之下,IRS-19处理组的有核股骨细胞数量显著减少。此外,用IRS-19处理导致血清集落刺激活性持续增加,随后股骨骨髓和脾脏中的GM-CFC再增殖增强。在辐射防护方面,在辐照前24小时而不是辐照后给药似乎最有效。在小鼠中,静脉注射而不是腹腔注射和口服是最有效的给药途径。此外,单次高剂量注射似乎比重复低剂量注射更有效。结果表明,与IRS-19给药相关的辐射防护特性很大程度上是诱导造血集落刺激活性以及可能激活和/或增强受体动物细胞因子级联反应的结果。这些变化最终可能影响造血细胞的细胞周期谱,从而影响它们承受和/或从辐射损伤中恢复的能力。